$Jumia Technologies (JMIA.US)$
There has been a major crash after the financial results. It would be premature to grab this place as a fallen knife. I think it will probably fall too much once and then rebound again.
Statistically, it is expected to drop to around $2 to $3.
If you're speaking from a long-term perspective, don't add it here; add it when it falls. If you look at it from a short-term perspective, the correct answer is to run away if you fight back.
There has been a major crash after the financial results. It would be premature to grab this place as a fallen knife. I think it will probably fall too much once and then rebound again.
Statistically, it is expected to drop to around $2 to $3.
If you're speaking from a long-term perspective, don't add it here; add it when it falls. If you look at it from a short-term perspective, the correct answer is to run away if you fight back.
Translated
20
1
$Aquestive Therapeutics (AQST.US)$
One of my favorite bio stocks.
Although negative financial results were expected compared to the same period last year, the settlement was positive. There is no doubt that a great product will come out by the end of 2025, so I think it's really time to buy it.
The reason it has been sold until now is due to excessive expectations and product delays. The essence of product awesomeness remains unchanged.
One of my favorite bio stocks.
Although negative financial results were expected compared to the same period last year, the settlement was positive. There is no doubt that a great product will come out by the end of 2025, so I think it's really time to buy it.
The reason it has been sold until now is due to excessive expectations and product delays. The essence of product awesomeness remains unchanged.
Translated
5
$BioXcel Therapeutics (BTAI.US)$
Compared to the same period last year, sales doubled, and the deficit was drastically reduced. The consensus has also been exceeded. The situation is bad, so I don't know how far it will go, but it's something to watch today.
Compared to the same period last year, sales doubled, and the deficit was drastically reduced. The consensus has also been exceeded. The situation is bad, so I don't know how far it will go, but it's something to watch today.
Translated
2
$BioXcel Therapeutics (BTAI.US)$
One of my favorite bio stocks.
Profitability is improving, so it may increase with the current financial results. Wouldn't they go to a pretty good place depending on the closing air on Monday?
One of my favorite bio stocks.
Profitability is improving, so it may increase with the current financial results. Wouldn't they go to a pretty good place depending on the closing air on Monday?
Translated
2